PMID: 40454964 Cell Signal2025 Apr 15:132:111807
The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2
Broad-spectrum sunscreen with SPF 30 or higher, protective clothing, and avoiding peak sun hours reduce photoaging
J., Seo, H
Company Profile Nexus Pharma Co.,Ltd
Surnomm le matre antioxydant , le glutathion est galement utilis dans les mcanismes de dtoxification cellulaire, et le recyclage dautres antioxydants comme la vitamine E